To achieve our ambitious strategy to become a leading biotech company in the development of single-strain keystone biotherapies, we are open to welcome new investors.
Established in 2010, YSOPIA Bioscience has already raised €22.7M.
We are backed by renowned and valuable investors.
Seventure Partners / Health For Life Capital, Europe’s leading microbiome innovation investment fund, is our historic lead investor.
Three family offices have also backed YSOPIA Bioscience, as well as public investors, including the Nouvelle Aquitaine region. We also received support from BPI France.